Among POMGNT1-related α-dystroglycanopathies, muscle–eye–brain (MEB) disease presents with congenital muscular dystrophy, structural brain abnormalities, and retinal dystrophy. Here, POMGNT1 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.